New study aims to predict painful skin rash in incontinent patients
NCT ID NCT06978751
First seen Jun 01, 2026 · Last updated Jun 18, 2026 · Updated 3 times
Summary
This study followed 271 adults in hospitals who have incontinence but no skin rash yet. Researchers checked daily for a rash called incontinence-associated dermatitis (IAD) and recorded factors like age, sex, and stool type. The goal was to see which factors best predict who will get the rash, so a risk assessment tool can be developed to help prevent it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCONTINENCE ASSOCIATED DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AZ Delta
Rumbeke, Belgium
-
AZ Groeninge
Kortrijk, Belgium
-
AZ Sint-Lucas
Ghent, Belgium
-
AZ West
Veurne, Belgium
-
Sint-Jozefskliniek
Izegem, Belgium
-
University Hospital Ghent
Ghent, Belgium
-
Uppsala University Hospital
Uppsala, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.